Saturday, February 22, 2025
- Advertisement -spot_img

TAG

demis hassabis

Google DeepMind CEO Demis Hassabis ‘Calm and Confident’ About AI Strategy | PYMNTS.com

Google DeepMind CEO Demis Hassabis reportedly told employees Wednesday (Feb. 12) that he is not worried...

Google’s AI head wants employees to chill out over DeepSeek

In This StoryDespite it rattling markets and Silicon Valley, Google’s (GOOGL-0.41%) artificial intelligence head isn’t worried about Chinese AI startup, DeepSeek.Elon Musk denies knowledge...

A top Google AI exec says there’s nothing new about DeepSeek

In This StoryDespite rattling global tech stocks with competitive artificial intelligence models, Chinese AI startup DeepSeek didn’t introduce anything new, a Google (GOOGL+0.65%) executive...

After Sundar Pichai, Google DeepMind CEO praises DeepSeek but says “despite the hype, there’s no…” – The Times of India

Google DeepMind CEO Demis Hassabis praised Deepseek's AI model as “probably the best work” from China, acknowledging its impressive engineering and geopolitical...

Deepseek’s AI model is ‘the best work’ out of China but the hype is ‘exaggerated,’ Google Deepmind CEO says

Google DeepMind co-founder and Chief Executive Officer Demis Hassabis gives a conference during the Mobile World Congress (MWC), the telecom industry's biggest annual gathering,...

Google ditched its pledge not to use AI for weapons and surveillance

In This StoryGoogle (GOOGL-7.59%) has changed its mind on building military AI.The change appears in the tech giant’s Responsible AI Progress Report for 2024,...

Google pledge against using AI for weapons vanishes

Google on Tuesday updated its principles when it comes to artificial intelligence, removing vows not to use the technology for weapons or surveillance.Revised AI...

Google earnings are coming. Here’s what to expect

In This StoryAlphabet (GOOGL+1.33%) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.What DeepSeek’s AI breakthrough means for Meta,...

Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says

In This StoryDrugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of...

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today. The rally comes...

Google.org commits $20m for AI-driven scientific research

Google.org, the philanthropic arm of Google, has announced a commitment of $20m in cash and $2m in cloud credits to...

Latest news

- Advertisement -spot_img